Legal

Notice of Privacy Practices

Effective Date: February 2026

THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.

1. Our Pledge Regarding Your Health Information

Rymeda, Inc. ("Rymeda," "we," "us," or "our") understands that health information about you is personal. We are committed to protecting your health information. This Notice of Privacy Practices ("Notice") applies to all Protected Health Information ("PHI") and electronic Protected Health Information ("ePHI") that Rymeda creates, receives, maintains, or transmits on behalf of healthcare providers ("Covered Entities") who use the Rymeda platform.

Rymeda acts as a Business Associate under the Health Insurance Portability and Accountability Act of 1996 ("HIPAA"), 42 USC §1320d et seq., the HIPAA Privacy Rule at 45 CFR Part 164 Subpart E, the HIPAA Security Rule at 45 CFR Part 164 Subpart C, the HIPAA Breach Notification Rule at 45 CFR Part 164 Subpart D, and the Health Information Technology for Economic and Clinical Health Act ("HITECH"), 42 USC §17921 et seq. Our obligations are further defined in our Business Associate Agreement.

This Notice describes our privacy practices with respect to PHI processed through the Rymeda platform, including clinical charts, clinical notes (SOAP notes, progress notes, intake notes, discharge summaries), voice recordings, AI-generated medical reports, diagnoses, medications, allergies, vital signs, lab results, treatment plans, billing records, insurance claims, appointment data, secure messages, and all associated metadata.

We are required by law to maintain the privacy of your PHI, provide you with this Notice of our legal duties and privacy practices, notify you following a breach of your unsecured PHI, and abide by the terms of this Notice currently in effect.

2. How We May Use and Disclose Your Protected Health Information

The following categories describe the ways in which Rymeda may use or disclose your PHI without your written authorization. Not every use or disclosure in a category is listed; however, all permitted uses and disclosures fall within one of the categories described below.

2.1 Treatment

Your PHI may be used and disclosed to provide, coordinate, or manage your healthcare and related services. This includes sharing clinical charts, SOAP notes, clinical notes, diagnoses (ICD-10 codes), medications, allergies, vital signs, lab results, treatment plans, and care team information among the healthcare providers involved in your care through the Rymeda platform. For example, a physician may access your clinical chart to review your problem list, medication history, and prior clinical notes when providing follow-up treatment. Care team members (physicians, nurse practitioners, physician assistants, registered nurses, and therapists) may access relevant portions of your clinical record based on their role and the minimum necessary standard.

2.2 Payment

Your PHI may be used and disclosed for payment-related activities. This includes billing, claims management, insurance verification, and collections. Specifically, the platform processes invoices containing CPT codes and line items, insurance claims with ICD-10 diagnosis codes and CPT procedure codes, and payment records. Billing staff may access payment-related information (but not clinical chart data) to submit claims to your insurance provider, process co-payments, and manage accounts receivable. PHI disclosed for payment purposes is limited to the minimum necessary to accomplish the payment activity.

2.3 Healthcare Operations

Your PHI may be used and disclosed for healthcare operations activities, including quality assessment and improvement, credentialing and peer review, compliance auditing, business management and administration, and training. The platform generates immutable audit trails for all PHI access events and supports provider credential verification through NPI/NPPES validation. Organization administrators and owners may access operational data (but not clinical chart data) for practice management purposes.

2.4 As Required By Law

We will disclose your PHI when required to do so by federal, state, or local law, including compliance with court orders, subpoenas, or other legal process. This includes disclosures required under HIPAA (45 CFR §164.512(a)), the California Confidentiality of Medical Information Act ("CMIA") (Cal. Civ. Code §56.10), and other applicable laws.

2.5 Public Health Activities

Your PHI may be disclosed for public health activities and purposes to a public health authority authorized by law to collect or receive the information for the purpose of preventing or controlling disease, injury, or disability (45 CFR §164.512(b)). This includes reporting to the Centers for Disease Control and Prevention (CDC), state and local health departments, and the Food and Drug Administration (FDA).

2.6 Health Oversight Activities

Your PHI may be disclosed to a health oversight agency for activities authorized by law, including audits, civil or criminal investigations, inspections, licensure, and disciplinary actions (45 CFR §164.512(d)). This includes oversight by the Department of Health and Human Services (HHS) Office for Civil Rights, the California Department of Public Health (CDPH), and state medical boards.

2.7 Judicial and Administrative Proceedings

Your PHI may be disclosed in the course of any judicial or administrative proceeding, in response to an order of a court or administrative tribunal (45 CFR §164.512(e)), or in certain conditions in response to a subpoena, discovery request, or other lawful process that is not accompanied by a court order, provided that reasonable efforts have been made to notify you or to secure a qualified protective order.

2.8 Law Enforcement

We may disclose your PHI to a law enforcement official for law enforcement purposes as required by law or in compliance with a court order, court-ordered warrant, subpoena, or summons issued by a judicial officer; a grand jury subpoena; or an administrative request (45 CFR §164.512(f)).

2.9 To Avert a Serious Threat to Health or Safety

We may use and disclose your PHI when necessary to prevent or lessen a serious and imminent threat to your health or safety or the health or safety of the public or another person (45 CFR §164.512(j)). Any disclosure will be made to a person reasonably able to prevent or lessen the threat, including the target of the threat.

2.10 Government Functions

We may disclose your PHI for specialized government functions, including military and veterans' activities, national security and intelligence activities, protective services for the President, and medical suitability determinations (45 CFR §164.512(k)).

2.11 Workers' Compensation

We may disclose your PHI as authorized by and to the extent necessary to comply with workers' compensation laws and other similar legally established programs (45 CFR §164.512(l)).

2.12 Research

We may use or disclose your PHI for research purposes only with your written authorization or when the use involves de-identified data in accordance with 45 CFR §164.514 or a limited data set with a data use agreement in accordance with 45 CFR §164.514(e). Research use of PHI requires approval by an Institutional Review Board (IRB) or privacy board in accordance with 45 CFR §164.512(i).

2.13 Decedents

We may disclose PHI to a coroner, medical examiner, or funeral director as necessary to carry out their duties (45 CFR §164.512(g)).

2.14 Organ and Tissue Donation

If you are an organ donor, we may disclose PHI to organizations involved in the procurement, banking, or transplantation of cadaveric organs, eyes, or tissue (45 CFR §164.512(h)).

3. Uses and Disclosures Requiring Your Written Authorization

The following uses and disclosures of your PHI require your written authorization before we may proceed. You may revoke any authorization at any time by submitting a written request to legal@rymeda.com. Revocation applies prospectively and does not affect any use or disclosure made in reliance on your authorization prior to revocation.

3.1 Marketing

We will not use or disclose your PHI for marketing purposes without your prior written authorization, as required by 45 CFR §164.508(a)(3) and 42 USC §17936(a). We will not sell your PHI without your written authorization, as required by 42 USC §17935(d).

3.2 Sale of PHI

We will not sell your PHI to any third party without your prior written authorization. This prohibition applies regardless of the form or medium in which the PHI is maintained, in accordance with 42 USC §17935(d)(2).

3.3 Psychotherapy Notes

Uses and disclosures of psychotherapy notes, as defined in 45 CFR §164.501, require your written authorization except for limited purposes set forth in 45 CFR §164.508(a)(2), including use by the originator of the notes for treatment, for use in training programs, and for defense in legal proceedings.

3.4 AI Processing of Clinical Data

Rymeda's platform includes AI-assisted clinical documentation features that process your health information. You will be asked for separate, specific consent before any AI processing of your clinical data occurs. The following AI processing activities require your authorization:

  • Voice recording of clinical encounters: Clinical encounters may be audio-recorded using the Rymeda platform. Recording requires your explicit, per-encounter consent in compliance with California Penal Code §632 (two-party consent). You may refuse or withdraw consent for any individual encounter without affecting your care.
  • AI transcription: Audio recordings are transmitted to AI language model services (including OpenAI Whisper and Google Gemini) for transcription. Recordings are encrypted in transit (TLS 1.3) and at rest (AES-256) and processed through our PHI redaction pipeline before reaching third-party AI services where technically feasible.
  • AI-generated clinical documentation: Transcriptions are processed by AI models to generate structured SOAP notes (Subjective, Objective, Assessment, Plan), suggested ICD-10 diagnosis codes with confidence scores, visit summaries, suggested problem list entries, and follow-up recommendations.
  • AI model versioning: All AI-generated content includes the AI model version identifier and generation timestamp for full provenance tracking.

See Section 5 below for detailed disclosures about AI-assisted clinical documentation, including your right to opt out.

4. Your Rights Regarding Your Protected Health Information

You have the following rights with respect to your PHI. To exercise any of these rights, submit a written request to legal@rymeda.com.

4.1 Right to Inspect and Copy (45 CFR §164.524)

You have the right to inspect and obtain a copy of your PHI contained in a designated record set, including clinical charts, clinical notes, voice note transcriptions, AI-generated medical reports, billing records, and insurance claims. We will respond to your request within thirty (30) days of receipt. If we are unable to respond within thirty (30) days, we may extend the response period by up to an additional thirty (30) days, provided we give you written notice of the extension. You may request your PHI in electronic format, and we will provide it in the electronic form and format you request if it is readily producible, or in a mutually agreed-upon alternative electronic format. We may charge a reasonable, cost-based fee for copies, in accordance with 45 CFR §164.524(c)(4).

We may deny your request in limited circumstances as permitted by 45 CFR §164.524(a)(2) and (a)(3). If we deny your request, we will provide you with a written explanation and information about how to request a review of the denial.

4.2 Right to Amend (45 CFR §164.526)

You have the right to request an amendment to your PHI in a designated record set if you believe the information is incorrect or incomplete. You must provide a reason for your amendment request. We will act on your request within sixty (60) days. If we are unable to act within sixty (60) days, we may extend the response period by up to an additional thirty (30) days, provided we give you written notice. We may deny your request if the information was not created by us, is not part of the designated record set, is not available for inspection as a matter of law, or is accurate and complete. If we deny your request, we will provide you with a written explanation of the denial and your right to submit a statement of disagreement.

4.3 Right to an Accounting of Disclosures (45 CFR §164.528)

You have the right to request an accounting of certain disclosures of your PHI made by Rymeda during the six (6) years prior to the date of your request (or since the effective date of this Notice, whichever is shorter). The accounting will not include disclosures made for treatment, payment, or healthcare operations; disclosures made to you or authorized by you; disclosures made incident to an otherwise permitted use or disclosure; or other disclosures for which an accounting is not required by law. The Rymeda platform maintains immutable, append-only audit trails for all PHI access events, which support the generation of disclosure accountings. The first accounting in any twelve (12) month period is provided free of charge. We may charge a reasonable, cost-based fee for subsequent accountings within the same period.

4.4 Right to Request Restrictions (45 CFR §164.522(a))

You have the right to request a restriction on the use or disclosure of your PHI for treatment, payment, or healthcare operations. You also have the right to request a restriction on disclosures to persons involved in your care or the payment for your care. We are not required to agree to your request unless the restriction involves a disclosure to a health plan for payment or healthcare operations purposes and the PHI relates solely to a healthcare item or service for which you have paid in full out of pocket (42 USC §17935(a)). If we agree to a restriction, we will comply with it except in an emergency.

4.5 Right to Confidential Communications (45 CFR §164.522(b))

You have the right to request that we communicate with you about your health information in a particular way or at a particular location. For example, you may request that we contact you only at a specific email address or phone number. We will accommodate reasonable requests. The Rymeda platform supports secure messaging through encrypted communication threads.

4.6 Right to a Paper Copy of This Notice

You have the right to obtain a paper copy of this Notice upon request, even if you have agreed to receive the Notice electronically. To request a paper copy, contact legal@rymeda.com.

4.7 Right to Breach Notification (45 CFR §164.404)

You have the right to be notified in the event of a breach of your unsecured PHI. Notification will be provided without unreasonable delay, and in no event later than sixty (60) calendar days after discovery of the breach. For additional details, see Section 8 below and our Breach Notification Policy.

5. AI-Assisted Clinical Documentation Disclosure

In accordance with California AB 3030 (Cal. Health & Safety Code §1279.6), Rymeda provides the following detailed disclosure regarding AI-assisted clinical documentation features available on the platform:

5.1 Voice Recording and Consent

Clinical encounters may be recorded using the Rymeda platform's voice note feature. Because California is a two-party consent state (Cal. Penal Code §632), explicit consent from all parties must be obtained before recording begins. Consent for recording is obtained separately from all other consents and authorizations. Consent is requested on a per-encounter basis — you may refuse recording for any individual encounter without affecting your care or your ability to use other platform features. Recorded audio is uploaded in supported formats (WebM, MP4, MPEG, WAV, OGG), encrypted at rest using AES-256, and stored in AWS S3 with per-tenant encryption keys managed by AWS KMS.

5.2 Transcription Pipeline

Voice recordings are processed through an AI transcription pipeline. Audio is transmitted via TLS 1.3 encrypted connections to AI transcription services, including OpenAI Whisper. The transcription service converts audio to text. Transcription status is tracked through the lifecycle: pending, processing, completed, or failed. Transcripts are stored alongside the original voice note record and are accessible only to authorized clinical staff with appropriate role-based permissions.

5.3 AI-Generated Medical Reports

Once a transcript is available, AI models (including OpenAI GPT and Google Gemini, accessed via LiteLLM) generate structured medical reports containing:

  • Structured SOAP notes — Subjective, Objective, Assessment, and Plan sections generated from the clinical encounter transcript.
  • Visit summary — A narrative summary of the clinical encounter.
  • Suggested ICD-10 diagnosis codes — Including description and confidence score for each suggested code.
  • Suggested problem list entries — Clinical problems identified from the encounter.
  • Follow-up recommendations — Including action, timeframe, and suggested assignee.
  • AI model version identifier — Tracked for full provenance and reproducibility.
  • Generation timestamp — The exact date and time the AI content was generated.

5.4 Human-in-the-Loop: Provider Review Requirement

All AI-generated clinical content is flagged with status "AI_DRAFT — REQUIRES PROVIDER REVIEW" and cannot be incorporated into the medical record until a licensed healthcare provider has reviewed, edited (if necessary), and signed the content.

The report lifecycle follows a strict workflow: AI-generated reports begin in "draft" status, advance to "reviewed" status when a provider edits or confirms the content, and reach "signed" status only when a provider with full clinical chart access (Physician, Nurse Practitioner, or Physician Assistant) affirmatively signs the report. Signing is irreversible. The signed report, along with the original voice recording, full transcript, and audit trail, is preserved as part of the clinical record.

AI-generated content does not constitute medical advice, clinical diagnosis, or treatment recommendation. Healthcare providers retain full responsibility for all clinical decisions, and AI outputs are intended solely as assistive tools subject to independent professional judgment.

5.5 Original Recording Preservation

The original audio recording is preserved in its entirety alongside the AI-generated transcript and report. Audio duration, file format, and storage location are tracked. The original recording serves as the authoritative source record and is retained in accordance with applicable medical record retention requirements (see Section 7 of our Privacy Policy).

5.6 Your Right to Opt Out of AI Processing

You have the right to opt out of AI processing of your clinical data at any time. If you opt out:

  • Your clinical encounters will not be recorded unless you provide separate, explicit recording consent.
  • No AI transcription or report generation will be performed on your clinical data.
  • Your healthcare provider will document your encounter using manual methods.
  • Your decision to opt out will not affect the quality of care you receive or your access to any other platform features.
  • You may opt out on a per-encounter basis or globally for all future encounters.

To opt out, inform your healthcare provider before the encounter begins or contact legal@rymeda.com.

5.7 Provenance and Audit Trail

Every action in the voice note and AI documentation lifecycle is recorded in an immutable, append-only audit trail. The audit trail captures: the user ID and clinical role of the actor, the timestamp and IP address, the entity type and entity ID, and the action performed (uploaded, transcribed, report_generated, report_edited, signed). The full provenance chain — from recording upload to final signature — is available to authorized clinical staff through the platform and is retained for a minimum of six (6) years in accordance with 45 CFR §164.530(j).

6. Minimum Necessary Standard and Access by Role

In accordance with 45 CFR §164.502(b), Rymeda applies the minimum necessary standard to all uses, disclosures, and requests for PHI. Access to PHI on the Rymeda platform is governed by role-based access controls ("RBAC") that restrict data access based on clinical role and verification status. Only staff members with "verified" credential status may access clinical data.

The following access matrix defines what each clinical role may access:

RoleClinical Chart AccessOperational AccessAdmin Access
PhysicianFull — All clinical data, all patientsYesNo
Nurse Practitioner (NP)Full — All clinical data, all patientsYesNo
Physician Assistant (PA)Full — All clinical data, all patientsYesNo
Registered Nurse (RN)Scoped — Own notes and assigned patientsYesNo
TherapistScoped — Own notes and assigned patientsYesNo
BillerNone — No clinical chart accessBilling onlyNo
Front DeskNone — No clinical chart accessScheduling onlyNo
Org AdminNone — No clinical chart accessYesLimited
OwnerNone — No clinical chart accessYesFull

Scoped access means the user can only view clinical data for patients they are directly assigned to or for records they authored. For voice notes, users with scoped access can only view their own recordings. Users with full access can view clinical data across all patients within their organization. No role provides cross-organization access — tenant data isolation ensures complete separation between organizations.

7. How We Protect Your Information

Rymeda implements administrative, physical, and technical safeguards to protect your PHI in accordance with the HIPAA Security Rule (45 CFR Part 164, Subpart C). For complete details, see our Security page.

  • Encryption at rest: AES-256 encryption for all PHI stored in databases and file storage (AWS S3), with dedicated, per-tenant encryption keys managed by AWS Key Management Service (KMS).
  • Encryption in transit: TLS 1.3 for all data transmitted between clients, servers, and third-party services.
  • Access controls: Role-based access control (RBAC) and attribute-based access control (ABAC) enforcing the principle of least privilege, as described in Section 6 above.
  • Tenant data isolation: Complete data separation between organizations with isolated compute, storage, and network boundaries. Zero cross-tenant data visibility.
  • PHI redaction pipeline: Automated detection and redaction of PHI before data reaches AI processing layers, using multi-stage ML-powered entity recognition.
  • Immutable audit trails: Tamper-evident, append-only audit logs for every user action, data access, and system event, retained for a minimum of six (6) years.
  • Credential verification: Provider identity verified through NPI/NPPES validation, license verification, and ongoing monitoring. Only verified staff can access clinical data.
  • Infrastructure security: VPC isolation, Web Application Firewall (WAF), DDoS mitigation, container security, continuous vulnerability scanning, and automated patching.

8. Breach Notification

In the event of a breach of your unsecured PHI, Rymeda will notify affected individuals and authorities in accordance with the HIPAA Breach Notification Rule (45 CFR Part 164, Subpart D) and applicable state law:

  • Individual notification: You will be notified without unreasonable delay, and in no event later than sixty (60) calendar days after discovery of the breach, via first-class mail or email (if you have consented to electronic notice). Notification will describe what happened, the types of PHI involved, steps you should take to protect yourself, what we are doing to investigate and mitigate the breach, and contact information for further questions.
  • HHS notification: If a breach affects 500 or more individuals, the Secretary of HHS will be notified without unreasonable delay. If a breach affects fewer than 500 individuals, notification will be provided to HHS through an annual breach log submitted by February 28 of the following year.
  • Media notification: If a breach affects 500 or more residents of a single state or jurisdiction, prominent media outlets serving that state or jurisdiction will be notified without unreasonable delay.

California-Specific Requirements

  • SB 446 (Cal. Civ. Code §1798.82): Notification to affected California residents without unreasonable delay. Notification to the California Attorney General when more than 500 California residents are affected.
  • HSC §1280.15: Reporting to the California Department of Public Health (CDPH) within fifteen (15) business days when applicable.
  • CMIA (Cal. Civ. Code §56.36): Notification as required for breaches involving medical information of California residents.

For complete details, see our Breach Notification Policy and the breach notification provisions in our Business Associate Agreement.

9. California-Specific Disclosures

9.1 Confidentiality of Medical Information Act (CMIA)

For California residents, medical information processed through the Rymeda platform is additionally protected under the Confidentiality of Medical Information Act (Cal. Civ. Code §56 et seq.). Medical information will not be disclosed without valid written authorization from the patient, except as permitted under Cal. Civ. Code §56.10. Authorizations comply with the requirements of Cal. Civ. Code §56.11, including specificity of information, purpose, recipients, and expiration. Patients may revoke authorization at any time (Cal. Civ. Code §56.16), and revocation applies prospectively. All changes to medical records are automatically tracked in accordance with CMIA §56.101 audit requirements.

9.2 Two-Party Recording Consent (Cal. Penal Code §632)

California law requires the consent of all parties before recording a confidential communication. Rymeda's voice recording feature obtains explicit consent from all parties before recording begins. Consent is requested separately for each encounter and is independent of all other consents and authorizations. Violation of Cal. Penal Code §632 is a criminal offense punishable by fine of up to $2,500 and/or imprisonment. Rymeda does not record any communication without the affirmative consent of all parties.

9.3 AI Disclosure (AB 3030)

In accordance with California AB 3030 (Cal. Health & Safety Code §1279.6), Rymeda discloses that the platform uses artificial intelligence and machine learning technologies for clinical workflow automation, documentation, and decision support. AI-generated outputs are intended to assist — not replace — licensed healthcare professionals. All AI-generated clinical content is clearly labeled. Patients have the right to be informed when AI is used in their care and may request human review of any AI-assisted determination. See Section 5 above for complete AI disclosure details.

9.4 Three-Consent Model

For healthcare data processed through the Rymeda platform in California, we implement a three-consent model to ensure comprehensive authorization:

  • HIPAA Authorization: Written authorization for uses and disclosures of PHI not otherwise permitted by the HIPAA Privacy Rule (45 CFR §164.508).
  • CMIA Consent: Authorization for disclosure of medical information as required by Cal. Civ. Code §56.11.
  • Platform Consent: Informed consent for platform-specific data processing, including AI-assisted features, analytics, and data sharing with subprocessors.

Each consent is obtained independently and may be revoked independently. See our Patient Consent & Authorization Forms for detailed consent documents.

10. Changes to This Notice

We reserve the right to change the terms of this Notice and to make the revised Notice effective for all PHI we already have about you, as well as any PHI we receive in the future. If we make a material change to this Notice, we will post the revised Notice on this page with an updated effective date and provide notice to Covered Entities so they may inform their patients. The revised Notice will be effective for all PHI maintained by Rymeda as of the effective date of the revision. A copy of the current Notice will always be available on this page and upon request.

11. Complaints

If you believe your privacy rights have been violated, you may file a complaint with Rymeda or with the U.S. Department of Health and Human Services (HHS) Office for Civil Rights. You will not be penalized or retaliated against for filing a complaint.

  • Rymeda Privacy Officer: legal@rymeda.com
  • HHS Office for Civil Rights: U.S. Department of Health and Human Services, 200 Independence Avenue S.W., Washington, D.C. 20201. Phone: 1-877-696-6775. Website: hhs.gov/ocr/privacy/hipaa/complaints
  • California Department of Public Health (CDPH): For complaints related to California-specific medical privacy rights.

12. Contact Information

For questions about this Notice, to exercise your rights, or to request additional information about our privacy practices:

This Notice is provided in conjunction with our Privacy Policy, Business Associate Agreement, Data Processing Agreement, Terms of Service, and Patient Consent & Authorization Forms.